Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
ET-02 by EdiGene for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
ET-02 is under clinical development by EdiGene and currently in Phase II for B-Cell Non-Hodgkin Lymphoma. According to GlobalData, Phase...